A survey of medication responses in children and adolescents with fetal alcohol syndrome

J. Coe, J. Sidders, K. Riley, J. Waltermire, Randi J Hagerman

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

This paper describes the psychopharmacological interventions in patients with Fetal Alcohol Syndrome (FAS), Partial Fetal Alcohol Syndrome (PFAS) or Alcohol-related Neurodevelopmental Disorder (ARND). Methods: The pharmacological histories of patients who had a confirmed in-utero exposure to alcohol and were between the ages of 3.5 and 17 years were collected from a chart review of children seen in a child development unit over the previous seven years. Results: Twenty-two patients had 66 medications trials: 63% responded well to stimulants, 82% responded well to selective serotonin reuptake inhibitors (SSRIs), 88% responded well to a mood stabilizer and 83% responded well to an antipsychotic. Discussion: Aggressive treatment, including medication, should beneficially influence the broad range of secondary disabilities seen in these patients.

Original languageEnglish (US)
Pages (from-to)148-155
Number of pages8
JournalMental Health Aspects of Developmental Disabilities
Volume4
Issue number4
StatePublished - 2001

Fingerprint

Fetal Alcohol Spectrum Disorders
Serotonin Uptake Inhibitors
Child Development
Antipsychotic Agents
Alcohols
Pharmacology
Surveys and Questionnaires
Therapeutics

Keywords

  • Antipsychotic
  • Developmental disabilities
  • Fetal alcohol syndrome (FAS)
  • Mental retardation
  • Psychopharmacology
  • SSRI
  • Stimulants

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

A survey of medication responses in children and adolescents with fetal alcohol syndrome. / Coe, J.; Sidders, J.; Riley, K.; Waltermire, J.; Hagerman, Randi J.

In: Mental Health Aspects of Developmental Disabilities, Vol. 4, No. 4, 2001, p. 148-155.

Research output: Contribution to journalArticle

@article{24fcc3476b9b42749737578097f44861,
title = "A survey of medication responses in children and adolescents with fetal alcohol syndrome",
abstract = "This paper describes the psychopharmacological interventions in patients with Fetal Alcohol Syndrome (FAS), Partial Fetal Alcohol Syndrome (PFAS) or Alcohol-related Neurodevelopmental Disorder (ARND). Methods: The pharmacological histories of patients who had a confirmed in-utero exposure to alcohol and were between the ages of 3.5 and 17 years were collected from a chart review of children seen in a child development unit over the previous seven years. Results: Twenty-two patients had 66 medications trials: 63{\%} responded well to stimulants, 82{\%} responded well to selective serotonin reuptake inhibitors (SSRIs), 88{\%} responded well to a mood stabilizer and 83{\%} responded well to an antipsychotic. Discussion: Aggressive treatment, including medication, should beneficially influence the broad range of secondary disabilities seen in these patients.",
keywords = "Antipsychotic, Developmental disabilities, Fetal alcohol syndrome (FAS), Mental retardation, Psychopharmacology, SSRI, Stimulants",
author = "J. Coe and J. Sidders and K. Riley and J. Waltermire and Hagerman, {Randi J}",
year = "2001",
language = "English (US)",
volume = "4",
pages = "148--155",
journal = "Mental Health Aspects of Developmental Disabilities",
issn = "1057-3291",
publisher = "Psych-Media Inc.",
number = "4",

}

TY - JOUR

T1 - A survey of medication responses in children and adolescents with fetal alcohol syndrome

AU - Coe, J.

AU - Sidders, J.

AU - Riley, K.

AU - Waltermire, J.

AU - Hagerman, Randi J

PY - 2001

Y1 - 2001

N2 - This paper describes the psychopharmacological interventions in patients with Fetal Alcohol Syndrome (FAS), Partial Fetal Alcohol Syndrome (PFAS) or Alcohol-related Neurodevelopmental Disorder (ARND). Methods: The pharmacological histories of patients who had a confirmed in-utero exposure to alcohol and were between the ages of 3.5 and 17 years were collected from a chart review of children seen in a child development unit over the previous seven years. Results: Twenty-two patients had 66 medications trials: 63% responded well to stimulants, 82% responded well to selective serotonin reuptake inhibitors (SSRIs), 88% responded well to a mood stabilizer and 83% responded well to an antipsychotic. Discussion: Aggressive treatment, including medication, should beneficially influence the broad range of secondary disabilities seen in these patients.

AB - This paper describes the psychopharmacological interventions in patients with Fetal Alcohol Syndrome (FAS), Partial Fetal Alcohol Syndrome (PFAS) or Alcohol-related Neurodevelopmental Disorder (ARND). Methods: The pharmacological histories of patients who had a confirmed in-utero exposure to alcohol and were between the ages of 3.5 and 17 years were collected from a chart review of children seen in a child development unit over the previous seven years. Results: Twenty-two patients had 66 medications trials: 63% responded well to stimulants, 82% responded well to selective serotonin reuptake inhibitors (SSRIs), 88% responded well to a mood stabilizer and 83% responded well to an antipsychotic. Discussion: Aggressive treatment, including medication, should beneficially influence the broad range of secondary disabilities seen in these patients.

KW - Antipsychotic

KW - Developmental disabilities

KW - Fetal alcohol syndrome (FAS)

KW - Mental retardation

KW - Psychopharmacology

KW - SSRI

KW - Stimulants

UR - http://www.scopus.com/inward/record.url?scp=0035654901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035654901&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0035654901

VL - 4

SP - 148

EP - 155

JO - Mental Health Aspects of Developmental Disabilities

JF - Mental Health Aspects of Developmental Disabilities

SN - 1057-3291

IS - 4

ER -